Related references
Note: Only part of the references are listed.Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2
Christopher Jonathan Daraius Austin et al.
AMINO ACIDS (2010)
The Absence of IDO Upregulates Type I IFN Production, Resulting in Suppression of Viral Replication in the Retrovirus-Infected Mouse
Masato Hoshi et al.
JOURNAL OF IMMUNOLOGY (2010)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Helen J. Ball et al.
GENE (2007)
Bacterial expression and characterization of molluscan IDO-like myoglobin
Hajime Julie Yuasa et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2007)
Quantitative and spatial differences in the expression of tryptophan-metabolizing enzymes in mouse epididymis
A Britan et al.
CELL AND TISSUE RESEARCH (2006)
Tissue microcircumstances for leukocytic infiltration into the testis and epididymis in mice
M Itoh et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2005)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
CTLA-4-Ig regulates tryptophan catabolism in vivo
U Grohmann et al.
NATURE IMMUNOLOGY (2002)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Share Paper
